Laxido Paediatric Plain (Sodium Hydrogen Carbonate, Potassium Chloride, Sodium Chloride, Macrogol 3350)

Macrogol 3350 is a high‑molecular‑weight polymer that remains in the intestinal lumen and draws water osmotically into the bowel. The added water softens the stool and expands its volume, which stimulates peristalsis and promotes regular bowel movements without being absorbed into the bloodstream.

The dose of Laxido Paediatric Plain is individualized by a qualified prescriber based on the child’s age, weight, severity of constipation, and response to therapy. Healthcare professionals calculate the appropriate amount and provide specific instructions for preparation and administration.

Safety data for Laxido Paediatric Plain in pregnancy or lactation are limited. It is generally recommended to avoid use unless clearly needed and prescribed by a physician. Women who are pregnant or breastfeeding should discuss potential risks and benefits with their healthcare provider before starting treatment.

To order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials. After confirmation, the sales team provides pricing, availability, shipping details and any necessary import documentation.

Laxido Paediatric Plain belongs to the osmotic laxative class, similar to lactulose or polyethylene glycol‑based products. Compared with stimulant laxatives, it generally has a gentler onset and a lower risk of cramping. Its electrolyte‑balanced formulation helps maintain serum levels, making it a preferred option for children who need a mild, effective laxative.

The product should be stored at ambient temperature, below 25 °C, in its original container. Keep it away from moisture, direct sunlight and heat sources. Ensure the packaging is tightly closed after each use to maintain product stability and prevent contamination.

Laxido Paediatric Plain is supplied as a powder that is dissolved in a measured amount of water or a suitable clear fluid. The resulting solution is given orally, usually once daily, according to the dose prescribed by the treating physician. The mixture should be consumed promptly after preparation.

The most serious risks include severe electrolyte imbalance, particularly low potassium or sodium levels, and dehydration, which can occur if fluid intake is insufficient. An allergic reaction presenting as rash, itching, swelling, or difficulty breathing is also a rare but critical concern that requires immediate medical attention.

Laxido Paediatric Plain should not be used in children with known or suspected intestinal obstruction, severe renal impairment, or a documented hypersensitivity to any of its ingredients. It is also contraindicated in patients who are already receiving high‑dose osmotic laxatives or diuretics without close medical supervision.